Lung cancer stages explained (TNM, 0–4)

Lung cancer is most often described in stages from 0 to 4. Stage 0 means abnormal cells are found only in the lining of the airway and have not spread. Stage 1 is a small cancer confined to the lung. Stage 2 is larger or has reached nearby lymph nodes. Stage 3 is locally advanced, with deeper chest lymph nodes involved but no distant spread. Stage 4 means the cancer has spread to other parts of the body. These number stages apply mainly to non-small cell lung cancer. Small cell lung cancer is often described instead as limited stage or extensive stage.

TNM is the standard system used to stage lung cancer worldwide. T stands for Tumour and describes how big the tumour is and whether it has grown into nearby structures. N stands for Nodes and describes whether the cancer has reached the lymph nodes, and which ones. M stands for Metastasis and describes whether the cancer has spread to distant parts of the body. Each letter is given a value from the scans and biopsy, and those values are combined to give an overall number stage from 0 to 4. TNM gives a more detailed picture than the number stage alone, which is why your team looks at both.

Staging brings together several tests rather than relying on one. A CT scan shows the size and position of the tumour, and a whole-body PET-CT helps reveal whether the cancer has spread. An MRI of the brain may be added. A biopsy confirms it is cancer and which type. Lymph nodes may be checked with scans or a procedure such as EBUS to assess the N in TNM. At CION, all of these results are reviewed together by a multidisciplinary tumour board, which agrees the TNM and the overall stage before any treatment plan is finalised.

Stage 0 lung cancer, also called carcinoma in situ, means abnormal cancer cells are found only in the top lining of the airway and have not grown into the deeper lung tissue or spread anywhere else. It is the earliest stage and is often treatable with the aim of removing the area completely, for example with surgery or treatment delivered through the airway. Lung cancer is rarely found this early, because it usually causes no symptoms at this point. It is most often picked up by chance on a scan done for another reason, or through screening in people at higher risk.

The key difference is distant spread. Stage 3 lung cancer is locally advanced — the tumour may be larger or have reached lymph nodes deeper in the chest, but it has not spread to distant organs. It is often treated with a combination of chemotherapy, radiation, surgery, and immunotherapy. Stage 4 lung cancer means the cancer has spread beyond the lung to distant parts of the body, such as the other lung, brain, bones, or liver. At stage 4 the aim of treatment shifts towards controlling the cancer across the body and protecting quality of life, guided by biomarkers, rather than removing it with surgery.

Stage 4 lung cancer is serious, but it is not automatically the end of the road, and the words "stage 4" alone do not decide your outlook. The aim of treatment shifts towards controlling the cancer throughout the body, easing symptoms, and protecting quality of life, often for a long time. Modern treatments — targeted therapy matched to a gene change, immunotherapy, chemotherapy, and precise radiation — can do this effectively for many people, and the options have grown considerably in recent years. The right approach depends on the cancer type, the biomarkers found on testing, and overall health, which is why each plan is individualised by the team.

Not quite. Non-small cell lung cancer (NSCLC) uses the full TNM number stages from 0 to 4. Small cell lung cancer (SCLC) is also given a TNM stage, but doctors very often describe it more simply as limited stage or extensive stage. Limited stage means the cancer is confined to one side of the chest and can be treated within a single radiation area, while extensive stage means it has spread more widely. This simpler grouping is used because it closely guides how SCLC is treated. This is why confirming the exact type with a biopsy is the first step before any stage truly makes sense.

The stage given at diagnosis does not change, even if the cancer later grows or responds to treatment. Doctors keep the original stage as a fixed reference point. However, there are different ways a stage can be described. Clinical stage is based on scans and tests before treatment, while pathological stage is based on what is found if surgery is done. If a cancer comes back after treatment, doctors describe this as a recurrence and may re-stage it to plan the next steps, but the first stage at diagnosis stays in the record. Your team will explain which staging they are referring to.

The stage is the single biggest factor in choosing treatment, but it is not the only one. Earlier stages can often be treated directly with surgery or precise radiation, while later stages move towards controlling the cancer across the body with targeted therapy, immunotherapy, chemotherapy, and radiation. Alongside the stage, your team also weighs the exact cell type, the biomarkers found on testing, your overall health, and your own wishes. At CION, all of this is brought together by a multidisciplinary tumour board so the plan reflects a team's combined judgement rather than a single opinion.

Seeking a second opinion on a lung cancer stage is reasonable and common, especially because the stage shapes the whole treatment plan. A second opinion can confirm that the staging is accurate, check that biomarker testing has been done, and make sure all suitable treatment options have been considered for that stage. It does not usually delay care, and it can bring real peace of mind. At CION, the first 45-minute consultation is free and doctor-led, and includes a written second opinion. You are under no obligation to start treatment — the aim is simply to give you a clear, honest picture so you can make a decision you feel settled with.